AAAAAA

   
Results: 1-14 |
Results: 14
ECONOMIC-EVALUATION OF SCREENING FOR PROSTATE-CANCER - A RANDOMIZED POPULATION-BASED PROGRAM DURING A 10-YEAR PERIOD IN SWEDEN
Authors: HOLMBERG H CARLSSON P LOFMAN O VARENHORST E
Citation: H. Holmberg et al., ECONOMIC-EVALUATION OF SCREENING FOR PROSTATE-CANCER - A RANDOMIZED POPULATION-BASED PROGRAM DURING A 10-YEAR PERIOD IN SWEDEN, Health policy, 45(2), 1998, pp. 133-147
IMPACT ON HEALTH-SERVICE COSTS OF MEDICAL TECHNOLOGIES USED IN MANAGEMENT OF PROSTATIC-CANCER
Authors: HOLMBERG H CARLSSON P KALMAN D VARENHORST E
Citation: H. Holmberg et al., IMPACT ON HEALTH-SERVICE COSTS OF MEDICAL TECHNOLOGIES USED IN MANAGEMENT OF PROSTATIC-CANCER, Scandinavian journal of urology and nephrology, 32(3), 1998, pp. 195-199
THE ANALGESIC EFFICACY OF CLODRONATE COMPARED WITH PLACEBO IN PATIENTS WITH PAINFUL BONE METASTASES FROM PROSTATIC-CANCER
Authors: STRANG P NILSSON S BRANDSTEDT S SEHLIN J BORGHEDE G VARENHORST E BANDMAN U BORCK L ENGLUND G SELIN L
Citation: P. Strang et al., THE ANALGESIC EFFICACY OF CLODRONATE COMPARED WITH PLACEBO IN PATIENTS WITH PAINFUL BONE METASTASES FROM PROSTATIC-CANCER, Anticancer research, 17(6D), 1997, pp. 4717-4721
BIOLOGIC VARIABILITY OF PROSTATE-SPECIFIC ANTIGEN AND ITS USEFULNESS AS A MARKER FOR PROSTATE-CANCER - EFFECTS OF FINASTERIDE
Authors: OESTERLING JE ROY J AGHA A SHOWN T KRARUP T JOHANSEN T LAGERKVIST M GORMLEY G BACH M WALDSTREICHER J LIEBER M HAMPSEY J POULSEN J EKMAN P JOHANSEN TEB HUDSON PB TAMMELA T MUSTONEN S VARENHORST E HJERTBERG H IMPERATOMCGINLEY J GINGELL JC THOMAS SA WOLF H LANGE P ELLIS W BAERT LVM BARTSCH G BEISLAND HO SUGIMOTO D EINARSON GV NURMI M IVERSEN P TOCKER P MALICE MP
Citation: Je. Oesterling et al., BIOLOGIC VARIABILITY OF PROSTATE-SPECIFIC ANTIGEN AND ITS USEFULNESS AS A MARKER FOR PROSTATE-CANCER - EFFECTS OF FINASTERIDE, Urology, 50(1), 1997, pp. 13-18
AGE-SPECIFIC REFERENCE VALUES FOR SERUM PROSTATE-SPECIFIC ANTIGEN IN A COMMUNITY-BASED POPULATION OF HEALTHY SWEDISH MEN
Authors: LOFMAN O LINDAHL T VARENHORST E
Citation: O. Lofman et al., AGE-SPECIFIC REFERENCE VALUES FOR SERUM PROSTATE-SPECIFIC ANTIGEN IN A COMMUNITY-BASED POPULATION OF HEALTHY SWEDISH MEN, Scandinavian journal of clinical & laboratory investigation, 57(3), 1997, pp. 225-232
MORBIDITY OF ULTRASOUND-GUIDED TRANSRECTAL CORE BIOPSY OF THE PROSTATE WITHOUT PROPHYLACTIC ANTIBIOTIC-THERAPY - A PROSPECTIVE-STUDY IN 415CASES
Authors: ENLUND AL VARENHORST E
Citation: Al. Enlund et E. Varenhorst, MORBIDITY OF ULTRASOUND-GUIDED TRANSRECTAL CORE BIOPSY OF THE PROSTATE WITHOUT PROPHYLACTIC ANTIBIOTIC-THERAPY - A PROSPECTIVE-STUDY IN 415CASES, British Journal of Urology, 79(5), 1997, pp. 777-780
RANDOMIZED STUDY OF CASODEX 50 MG MONOTHERAPY VS ORCHIECTOMY IN THE TREATMENT OF METASTATIC PROSTATE-CANCER
Authors: IVERSEN P TVETER K VARENHORST E
Citation: P. Iversen et al., RANDOMIZED STUDY OF CASODEX 50 MG MONOTHERAPY VS ORCHIECTOMY IN THE TREATMENT OF METASTATIC PROSTATE-CANCER, Scandinavian journal of urology and nephrology, 30(2), 1996, pp. 93-98
EFFICACY AND TOLERABILITY OF CASODEX IN PATIENTS WITH ADVANCED PROSTATE-CANCER
Authors: LUNGLMAYR G ALFTHAN O ALTWEIN JE BLACKLEDGE G BLACKLOCK NJ BONO A BOUFFIOUX C CHANNER K DEBRUYNE F DENIS L DISILVERIO F GRASSET D HAEFLINGER JM HARLAND S HEIJBROEK RP HOISAETER PA IVERSEN P JAEGER N KEUPPENS F KHOE GS KLARSKOV P KONTTURI M KUBER W KUMS JJM LARDENOYE JG LEDUC A LUNGLMAYR G MOEHRING K NEWLING D PAVONEMACALUSO M PERMI J RASMUSSEN F ROSSETTI SR SANDER S SARRAMON JP SMITH PH TVETER K TYRRELL CJ USAI E VALLANCIEN GMB VANCANGH PJ VARENHORST E WEISSBACH L WHELAN P WILLIAMS JL ZALCBERG J ZATTONI F DAWES PM
Citation: G. Lunglmayr et al., EFFICACY AND TOLERABILITY OF CASODEX IN PATIENTS WITH ADVANCED PROSTATE-CANCER, Anti-cancer drugs, 6(4), 1995, pp. 508-513
CAN FINASTERIDE REVERSE THE PROGRESS OF BENIGN PROSTATIC HYPERPLASIA - A 2-YEAR PLACEBO-CONTROLLED STUDY
Authors: ANDERSEN JT EKMAN P WOLF H BEISLAND HO JOHANSSON JE KONTTURI M LEHTONEN T TVETER K BODKER A VEDEL O NORDLING J POULSEN AL SCHOU J HVIDT V HANSEN JB MEYHOFF HH ELDRUP J HARTWELL D COLSTRUP H LYNGDORF P NIELSEN AH LARSEN E WALTER S LARSEN EH THYBO E MOMMSEN S BROK KE PALM L GENSTER H ANDERSEN M KAUPPINEN P RAUVALA M HAKKINEN J TAMMELA T TAINIO H HYNNINEN O TIITINEN J LEHTORANTA K ALAOPAS M PERTTILA I PETAS A RINTALA E SALMINEN R JUUSELA H HANSSON E VONWENDT R TUHKANEN K TALJA M NURMI M PUNTALA P PERMI J PUOLAKKA VM VIITANEN J GISLASON T EINARSSON GV ERI LM KARLSEN S HOLME P SIVERTSEN SM STEINSVIK E SERVOLL E URNES T MALME PA JOHANSEN TEB OMLAND H NAGELHUS J KLOSTER SE SKJEGGESTAD O VADA K MORTENSEN R NYBERG G PETTERSSON G WEDMAN L BRATELL S FOLMERZ P ZACKRISSON B DAHLGREN K TILLEGARD A AUS G BERGDAHL S HUGOSSON J HOLMQUIST B EK A RADEMARK C KRISTIANSEN P HERMANSSON CG PEDERSEN K OSCARSSON C KIHL B OLSSON JO NELVIN L LEISSNER KH LUNDSTAM S HJERTBERG H VARENHORST E ANDERSSON SO WINDAHL T SWARTZ R AHLBERG B GEDDA S ANDERSTROM C EDDELAND S HANSSON R STROGERG P ADOLFSSON J BAUER P KLEIST H STORM B RANCH T STRAVSNES H BREKKAN E EKLUND T KARLBERG L MALICE MP BRONEE V WENNERLUND P ERIKSSON LO AASERUD E LEHMUSSAARI J SUOMIN R GABRIEL MA
Citation: Jt. Andersen et al., CAN FINASTERIDE REVERSE THE PROGRESS OF BENIGN PROSTATIC HYPERPLASIA - A 2-YEAR PLACEBO-CONTROLLED STUDY, Urology, 46(5), 1995, pp. 631-637
CLINICAL AND ECONOMIC-CONSIDERATIONS IN THE TREATMENT OF PROSTATE-CANCER
Authors: VARENHORST E CARLSSON P PEDERSEN K
Citation: E. Varenhorst et al., CLINICAL AND ECONOMIC-CONSIDERATIONS IN THE TREATMENT OF PROSTATE-CANCER, PharmacoEconomics, 6(2), 1994, pp. 127-141
PREVALENCE AND DURATION OF HOT FLUSHES AFTER SURGICAL OR MEDICAL CASTRATION IN MEN WITH PROSTATIC-CARCINOMA
Authors: KARLING P HAMMAR M VARENHORST E
Citation: P. Karling et al., PREVALENCE AND DURATION OF HOT FLUSHES AFTER SURGICAL OR MEDICAL CASTRATION IN MEN WITH PROSTATIC-CARCINOMA, The Journal of urology, 152(4), 1994, pp. 1170-1173
QUALITY-OF-LIFE AFTER RADICAL RETROPUBIC PROSTATECTOMY FOR CARCINOMA OF THE PROSTATE
Authors: PEDERSEN KV CARLSSON P RAHMQUIST M VARENHORST E
Citation: Kv. Pedersen et al., QUALITY-OF-LIFE AFTER RADICAL RETROPUBIC PROSTATECTOMY FOR CARCINOMA OF THE PROSTATE, European urology, 24(1), 1993, pp. 7-11
MULTICENTER RANDOMIZED TRIAL COMPARING ZOLADEX WITH ZOLADEX PLUS FLUTAMIDE IN THE TREATMENT OF ADVANCED PROSTATE-CANCER - SURVIVAL UPDATE
Authors: TYRRELL CJ ALTWEIN JE KLIPPEL F VARENHORST E LUNGLMAYR G BOCCARDO F HOLDAWAY IM HAEFLIGER JM JORDAAN JP SOTARAUTA M
Citation: Cj. Tyrrell et al., MULTICENTER RANDOMIZED TRIAL COMPARING ZOLADEX WITH ZOLADEX PLUS FLUTAMIDE IN THE TREATMENT OF ADVANCED PROSTATE-CANCER - SURVIVAL UPDATE, Cancer, 72(12), 1993, pp. 3878-3879
INTEROBSERVER VARIATION IN ASSESSMENT OF THE PROSTATE BY DIGITAL RECTAL EXAMINATION
Authors: VARENHORST E BERGLUND K LOFMAN O PEDERSEN K
Citation: E. Varenhorst et al., INTEROBSERVER VARIATION IN ASSESSMENT OF THE PROSTATE BY DIGITAL RECTAL EXAMINATION, British Journal of Urology, 72(2), 1993, pp. 173-176
Risultati: 1-14 |